Fusion Pharmaceuticals Inc.
FUSN · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$94,897 | -$87,612 | -$81,047 | -$78,333 |
| Dep. & Amort. | $1,345 | $909 | $634 | $482 |
| Deferred Tax | $845 | -$3,162 | -$991 | -$576 |
| Stock-Based Comp. | $12,444 | $10,844 | $8,603 | $3,368 |
| Change in WC | -$1,317 | $3,660 | -$14,595 | $5,736 |
| Other Non-Cash | -$222 | $2,085 | $11,656 | $39,556 |
| Operating Cash Flow | -$81,802 | -$73,276 | -$75,740 | -$29,767 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,890 | -$2,142 | -$1,491 | -$1,123 |
| Net Acquisitions | $38,873 | -$25,229 | -$39,265 | -$9,700 |
| Inv. Purchases | -$230,570 | -$165,156 | -$172,469 | -$219,030 |
| Inv. Sales/Matur. | $191,697 | $190,385 | $211,734 | $9,700 |
| Other Inv. Act. | -$38,873 | $25,229 | $39,265 | $9,700 |
| Investing Cash Flow | -$42,763 | $23,087 | $37,774 | -$210,453 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $142,006 | $5,814 | $347 | $197,625 |
| Stock Repurch. | $0 | $1,285 | $0 | -$72,398 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $142,006 | $40,733 | $347 | $265,507 |
| Financing Cash Flow | $142,006 | $40,733 | $347 | $265,507 |
| Forex Effect | $169 | $0 | $0 | $0 |
| Net Chg. in Cash | $17,610 | -$9,456 | -$37,619 | $25,287 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $44,315 | $54,789 | $92,408 | $67,121 |
| End Cash | $61,925 | $45,333 | $54,789 | $92,408 |
| Free Cash Flow | -$85,692 | -$75,418 | -$77,231 | -$30,890 |